Vertex Resolves To Reverse English Funding Rejection For CRISPR Sickle Cell Gene Therapy

 
• By Neena Brizmohun
  
3d graphic of sickled blood cell
Casgevy is a one-off gene therapy for sickle cell disease • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe